Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd (GLENMARK) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 4,20,804
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,968.20
₹-5.60 (-0.28%)
1,957.00Low
Today’s Performance
1,988.00High
1,275.50Low
52 Week’s Performance
2,284.80High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.28%
  • 1 Week1.53%
  • 1 Month6.98%
  • 3 Months-0.86%
  • 6 Months30.47%
  • 1 Year27.45%
  • 3 Years65.45%
  • 5 Years31.43%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.58
  • 52-Week Low (₹)1,275.50
  • 52-Week High (₹)2,284.80
  • Price-to-Book (X)*5.81
  • Dividend Yield (%)0.13
  • Price-to-Earnings (P/E) (X)*55.17
  • Earnings Per Share (₹)35.78
  • Market Cap (₹ Cr.)*55,700.80
* Values as of last close price

bt_logoCOMPETITORS

BT TV

‘Actions With Partners, Including US’: Putin Updates PM Modi on Peace Moves in Ukraine Talks3:57‘Actions With Partners, Including US’: Putin Updates PM Modi On Peace Moves In Ukraine Talks
Does Putin Consider Trump A Peacemaker? Russian President’s Most Shocking Answer | Exclusive2:49Does Putin Consider Trump A Peacemaker? Russian President’s Most Shocking Answer | Exclusive
RBI Cuts Repo Rate By 25 BPS At 5.25% | Repo Rate Cut Impact On Markets, Economy & Rupee23:45RBI Cuts Repo Rate By 25 BPS At 5.25% | Repo Rate Cut Impact On Markets, Economy & Rupee
“India Has The Right”: Putin Slams U.S. Criticism, Says Trump Should Respect India–Russia Trade3:55“India Has The Right”: Putin Slams U.S. Criticism, Says Trump Should Respect India–Russia Trade
Putin’s India Visit: Defence, Trade & Strategy On Agenda As Modi Sets Stage For Key Talks1:54Putin’s India Visit: Defence, Trade & Strategy On Agenda As Modi Sets Stage For Key Talks
Alexander Stuglev | CEO Roscongress Foundation | Russia Wants To Deepen India Trade, Ease Trade Barriers For SMEs4:22Roscongress Foundation CEO | Russia Wants To Deepen India Trade, Ease Trade Barriers For SMEs
Putin In India: Russian President Hails 'Personal Bonds' And Rides With PM Modi In Delhi4:44Modi–Putin Car Diplomacy Returns | A Warm Welcome That Signals Deep Strategic Bonds
IndiGo Chaos: Mass Flight Cancellations Leave Passengers Stranded At Major Airports3:35IndiGo Chaos: Mass Flight Cancellations Leave Passengers Stranded At Major Airports
Putin To India Today: 'I Don't Think It Would Be Interesting For You To Be A Fly On The Wall' For 5-Hour Meet3:52Exclusive: President Putin On US ‘Shuttle Diplomacy’ After 5-Hour Meeting With Kushner
Putin in India: Why India Is Boosting Russia Ties Amid Western Pressure3:57Putin In India: Why India Is Boosting Russia Ties Amid Western Pressure
View more

bt_logoFAQ's

What was Glenmark Pharmaceuticals Ltd share price previously?
Glenmark Pharmaceuticals Ltd share price was down by -0.28% from the previous closing price of ₹1,973.80.
Who are peers of Glenmark Pharmaceuticals Ltd?
The peers of Glenmark Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Glenmark Pharmaceuticals Ltd?
The promotor/promotors of Glenmark Pharmaceuticals Ltd are Glenn Saldanha, Cheryl Pinto, Anurag Mantri, B E Saldanha, Sona Saira Ramasastry, Dipankar Bhattacharjee, V R Iyer, Pradeep Kumar Sinha, Harish Kuber.
What has been 52-week high of Glenmark Pharmaceuticals Ltd stocks?
The highest price of Glenmark Pharmaceuticals Ltd stock is ₹2,284.80 in the last 52-week.
What is the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) today on NSE?
As on Dec 05, 2025 Glenmark Pharmaceuticals Ltd (GLENMARK)’s share price on NSE is Rs 1968.2
What is the market cap of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The current market capitalisation of Glenmark Pharmaceuticals Ltd (GLENMARK) is 55,700.80 crores
What is Glenmark Pharmaceuticals Ltd Share symbol?
The symbol of Glenmark Pharmaceuticals Ltd is GLENMARK.
What is the PE ratio of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The current PE ratio of Glenmark Pharmaceuticals Ltd (GLENMARK) is 55.17.
What is the PB ratio of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The current PB ratio of Glenmark Pharmaceuticals Ltd (GLENMARK) is 5.81.
Today’s High & Low share prices of Glenmark Pharmaceuticals Ltd (GLENMARK) on NSE?
Today, the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) on NSE touched a high of Rs 1988 and a low of Rs 1957
What price did Glenmark Pharmaceuticals Ltd (GLENMARK) shares open on the NSE today?
On NSE, the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) opened at Rs 1964
What is the 52-week high of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The 52-week high price of Glenmark Pharmaceuticals Ltd (GLENMARK) is Rs 2,284.80
What is the 52-week low of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The 52-week low price of Glenmark Pharmaceuticals Ltd (GLENMARK) is Rs 1,275.50

bt_logoAbout Glenmark Pharma.

Glenmark Pharmaceuticals Ltd, incorporated in the year 1977, has its registered office in B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026, 91-22-40189999, 91-22-40189986. The main industry in which Glenmark Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Glenmark Pharmaceuticals Ltd is/are Suresh Surana & Associates LLP. In the main management, Glenn Saldanha is chairman and Harish Kuber is the company secretary for Glenmark Pharmaceuticals Ltd.

  • GS
    Glenn SaldanhaChairman / Executive Director / M D / Promoter
  • CP
    Cheryl PintoED / WTD / Promoter
  • AM
    Anurag MantriED / President / Global CFO
  • BES
    B E SaldanhaNon Executive Director
  • SSR
    Sona Saira RamasastryIndependent Non Exe. Director
  • DB
    Dipankar BhattacharjeeIndependent Non Exe. Director
  • VRI
    V R IyerIndependent Non Exe. Director
  • PKS
    Pradeep Kumar SinhaIndependent Non Exe. Director
  • HK
    Harish KuberCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.